Matching Entries: more than 10,000

    SDG 17
  • SDG-3 SDG-17
    Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances
    06 Jul 2021
    University of Sydney
    Orkin, Aaron M. Gill, Peter J. Ghersi, Davina Campbell, Lisa Sugarman, Jeremy Emsley, Richard Steg, Philippe Gabriel Weijer, Charles Simes, John Rombey, Tanja Williams, Hywel C. Wittes, Janet Moher, David Richards, Dawn P. Kasamon, Yvette Getz, Kenneth Hopewell, Sally Dickersin, Kay Wu, Taixiang Ayala, Ana Patricia Schulz, Kenneth F. Calleja, Sabine Boutron, Isabelle Ross, Joseph S. Golub, Robert M. Khan, Karim M. Mulrow, Cindy Siegfried, Nandi Heber, Joerg Lee, Naomi Kearney, Pamela Reed Wanyenze, Rhoda K. Hróbjartsson, Asbjørn Williams, Rebecca Bhandari, Nita Jüni, Peter Chan, An-Wen Orkin, Aaron M. Gill, Peter J. Ghersi, Davina Campbell, Lisa Sugarman, Jeremy Emsley, Richard Steg, Philippe Gabriel Weijer, Charles Simes, John Rombey, Tanja Williams, Hywel C. Wittes, Janet Moher, David Richards, Dawn P. Kasamon, Yvette Getz, Kenneth Hopewell, Sally Dickersin, Kay Wu, Taixiang Ayala, Ana Patricia Schulz, Kenneth F. Calleja, Sabine Boutron, Isabelle Ross, Joseph S. Golub, Robert M. Khan, Karim M. Mulrow, Cindy Siegfried, Nandi Heber, Joerg Lee, Naomi Kearney, Pamela Reed Wanyenze, Rhoda K. Hróbjartsson, Asbjørn Williams, Rebecca Bhandari, Nita Jüni, Peter Chan, An-Wen Kiermer, Veronique Corrigan-Curay, Jacqueline Concato, John

    Importance: Extenuating circumstances can trigger unplanned changes to randomized trials and introduce methodological, ethical, feasibility, and analytical challenges that can potentially compromise the validity of findings. Numerous randomized trials have required changes in response to the COVID-19 pandemic, but guidance for reporting such modifications is incomplete. Objective: As a joint exte…

  • SDG-17
    Did COVID-19 change spillover patterns between Fintech and other asset classes?
    06 Jul 2021
    University of Sydney
    Le, Lan-TN Yarovaya, Larisa Nasir, Muhammad Ali

    This study examines the spillover effect between financial technology (Fintech) stocks and other financial assets (gold, Bitcoin, a global equity index, crude oil, and the US Dollar) during the COVID-19 crisis. Employing daily data from June 2019 to August 2020, our empirical analysis shows that the outbreak of COVID-19 exacerbated volatility transmission across asset classes, while subsequent de…

  • SDG-3 SDG-17
    Audit of the Sydney Local Health District Public Health Unit notification and contact tracing system during the first wave of COVID_19
    16 Sep 2021
    University of Sydney
    Jain, Naveena Moore, Corey B. Quinn, Emma Liu, Huei Ming Liu, Darith Heaton, Maria Gehlot, Priyanka Dhakal, Yashoda Gupta, Leena Hogbin, Rebecca Eastwood, John G.

    OBJECTIVE: To conduct a real-time audit to assess a Continuous Quality Improvement (CQI) activity to improve the quality of public health data in the Sydney Local Health District (SLHD) Public Health Unit during the first wave of COVID-19. METHODS: A real-time audit of the Notifiable Conditions Information Management System was conducted for positive cases of COVID-19 and their close contacts fro…

  • SDG-8 SDG-17
    Locus of control and internal migration
    22 Sep 2021
    University of Sydney
    Caliendo, Marco Cobb-Clark, Deborah Hennecke, Juliane Uhlendorff, Arne

    We model migration across domestic labor markets (internal migration) as the outcome of a job search process in which job seekers form subjective beliefs about the return search effort that are related to their locus of control. Job seekers with an internal locus of control are predicted to search across larger geographic areas and migrate more frequently as a result. We empirically test the rela…

  • SDG-3 SDG-17
    Developing a Global Community of Practice for Pharmacy Workforce Resilience-Meet GRiT
    19 Oct 2021
    University of Sydney
    Whitfield, Karen Arya, Vibhuti Austin, Zubin Bajis, Dalia Bradley, Catriona Clark, Bronwyn Exintaris, Betty Galbraith, Kirsten Hajj, Maguy Saffouh El Hall, Kat Hughes, Louise Kirsa, Sue Langran, Catherine Mantzourani, Efi Wilby, Kyle John Willis, Sarah

    Workforce resilience in pharmacy is required to ensure the practice, education, and administrative systems remain viable and sustainable over time and when facing challenges. Whether it is addressing burnout of pharmacists or students, or the structure and policies/procedures of employment and professional organizations, working to increase resilience across all individuals and sectors is essenti…

  • SDG-17
    Documenting elimination of co-circulating COVID-19 clusters using genomics in New South Wales, Australia
    26 Nov 2021
    University of Sydney
    Arnott, Alicia Draper, Jenny Rockett, Rebecca J. Lam, Connie Sadsad, Rosemarie Gall, Mailie Martinez, Elena Byun, Roy Musto, Jennie Marais, Ben Chen, Sharon C.-A. Kok, Jen Dwyer, Dominic E. Sintchenko, Vitali

    ObjectiveTo adapt 'fishplots' to describe real-time evolution of SARS-CoV-2 genomic clusters.ResultsThis novel analysis adapted the fishplot to depict the size and duration of circulating genomic clusters over time in New South Wales, Australia. It illuminated the effectiveness of interventions on the emergence, spread and eventual elimination of clusters and distilled genomic data into clear inf…

  • SDG-3 SDG-17
    What is health promotion ethics?
    12 Jan 2015
    University of Sydney
    Carter, SM

    What does it mean to think about the ethics of health promotion? When most of us think ‘ethics’ we think of the Human Research Ethics Committee applications required for research projects. But I’m thinking of something quite different here: the ethics of health promotion practice. Health promotion ethics is an attempt to answer questions such as: Can we provide a moral justification for what we a…

  • SDG-3 SDG-17
    Communication of genetic information within families: the case for familial comity
    02 Feb 2015
    University of Sydney
    Davey, A Newson, A.J. O’Leary, P

    Advances in genetic technologies raise a multitude of ethical issues, some of which give rise to novel dilemmas for medical practice. One of the most controversial problems arising in clinical genetics is that of confidentiality and who may disclose genetic health information. This paper considers the question of when it is appropriate for health professionals to disclose clinically significant g…

  • SDG-17
    Propaganda or cost of innovation? The high price of new drugs
    18 Jun 2015
    University of Sydney
    Ghinea, N Kerridge, I Lipworth, W

    Ever wonder how much it costs to develop a new drug? The independent, non-profit research group, The Tufts Center for the Study of Drug Development, estimates US$2.6 billion, almost double the centre’s previous estimate a decade ago. But how accurate is this figure? While the details of the study remain a secret, a press release, slideshow and background document on the Tufts website provide some…

  • SDG-17
    Justifying Knowledge, Justifying Method, Taking Action: Epistemologies, Methodologies, and Methods in Qualitative Research
    14 Mar 2016
    University of Sydney
    Carter, SM Little, M

    In this article, the authors clarify a framework for qualitative research, in particular for evaluating its quality, founded on epistemology, methodology, and method. They define these elements and discuss their respective contributions and interrelationships. Epistemology determines and is made visible through method, particularly in the participant— researcher relationship, measures of research…